🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluating Primary Suicide Prevention in Adolescents With Risk Factors

RecruitingNAAges 14 Years - 25 YearsAllStephanie Baggio
NCT06551038 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Suicide is one of the main causes of death among teenagers. Because it is preventable, primary prevention of suicide has become a public health priority, with encouraging results in promoting suicide awareness and reducing suicidal thoughts among adolescents. However, the lack of studies conducted among vulnerable populations (i.e., marginalised, disengaged and disadvantaged) is a major gap, even though these populations present an increased risk of suicidal behaviour. The aim of this project is to test the effectiveness of a brief primary suicide prevention intervention for vulnerable adolescents, using a randomised controlled trial. Vulnerable adolescents include those 1) detained in juvenile detention centres, 2) at risk of dropping out of school, 3) undergoing treatment for psychiatric disorders, 4) belonging to a sexual or gender diversity, 5) affected by chronic conditions, or 6)

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Vulnerable adolescents defined as being: 1) detained in juvenile detention centers, 2) disconnected from school, 3) in treatment for psychiatric disorders, 4) belonging to a sexual or gender minority, 5) affected by chronic conditions, or 6) with relational/familial problems. * Age 14 to 25 years old. * Good knowledge of French. * Accepting to sign the informed consent. Exclusion Criteria: * The medical/educational staff considers that the intervention will interfere with appropriate management of acute psychiatric disorder or may cause harm to self or other. * Being enrolled in another suicide prevention intervention during the study period.
💊

What it tests

  • Primary suicide prevention intervention
  • Art-based control intervention
📍

Where

19 sites
Dialogai et Totem
Geneva, Switzerland
Programme ForMe (anciennement SEMO) et dispositif ProPULSE
Plan-les-Ouates, Switzerland
Centre de Détention et d'Observation La Clairière
Vernier, Switzerland
Programme Intégration et Formation Professionnelle
Vernier, Switzerland
Agnodice
Lausanne, Switzerland
Vogay
Lausanne, Switzerland
Centre Thérapeutique de Jour pour Adolescents
Lausanne, Switzerland
Unité de Soins Psychiatriques Fermée pour Mineurs
Lausanne, Switzerland

…and 11 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy